A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

Completed · Phase 3

Conditions studied: Dry Eye Syndromes

In brief

A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.

Key facts

Study ID

NCT02455050

Run by

Allergan

People needed

79

Starts

2014-12-01

Expected to finish

2015-08-01

Last updated by the study team

2017-01-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current use of an artificial tear product
• Visual Acuity of at least 20/40 (while wearing glasses, if necessary).

You may not qualify if…

• Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study
• Cataract surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy within 6 months
• Use of RESTASIS® Cyclosporine Ophthalmic Emulsion or any topical cyclosporine within 3 months
• Diagnosis of glaucoma.

Where it is running

• Study site — Azusa, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.